Topics: Stories from Slate - Slate Magazine
© 2017 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong ® is a registered trademark of CDM Publishing, LLC.
© 2017 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong ®
is a registered trademark of CDM Publishing, LLC.
Researchers have for the first time documented a case of an individual contracting HIV, a multi-drug resistant strain, while apparently adhering well to the daily regimen of Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis ( PrEP ). The scientists concluded that it is indeed possible for individuals who are adherent to PrEP to contract HIV when they are exposed to a virus that is resistant to both drugs included in Truvada.